University of Patras
Ανάδειξη νέων πρώιμων βιοδεικτών εξέλιξης της χρόνιας νεφρικής νόσου στον ορό, τα ούρα και τον νεφρικό ιστό μη διαβητικών ασθενών με χρόνια νεφρική νόσο
Abstract
dc:descriptionThe need for timely identification of patients with CKD who are at an increased risk of developing progressive disease and End Stage Kidney Disease is imperative. The traditional prognostic markers of CKD, eGFR and albuminuria, have serious disadvantages, so it is imperative to identify new, more effective prognostic biomarkers for CKD. Nine proteins- either fibrotic or inflammatory markers- were studied as potential prognostic markers in 278 patients with CKD of all stages and various etiologies and a control group of 20 people. The biomarkers were measured with sandwich ELISA. Depending on the course of eGFR during a follow-up time of 20.7 ± 9.9 months, patients were divided into progresors (ΔeGFR> -3.5 ml / min / 1.75 m2 / year) and non-progresors (ΔeGFR≤ - 3.5 ml / min / 1.75 m2 / year) and the levels of biomarkers upon enrollement were compared between patients and the control group and between progresors and non-progresors in both the total population of patients as well as in patient subgroups based on CKD etiology (patients with chronic glomerulonephritis, renal transplant recipients and patients with albuminuria <150 mg / g). In addition, biomarker levels were correlated with patients' eGFR and proteinuria. All biomarkers were negatively correlated with eGFR except one. The degree of proteinuria was positively correlated with four of them. The mean values of all biomarkers showed a statistically significant difference between the control group and patients with different stages of CKD. Out of the 271 patients with data on the course of their renal function, 83 were progresors and 188 non-progresors. The levels of five biomarkers at the start of monitoring showed a statistically significant difference between the two groups. In the subgroup of patients with Chronic Glomerulonephritis there were 28 progresors and 42 non-progresors. Similarly to the total cohort, five biomarkers at the start of follow-up showed a statistically significant difference between progresors and non-progresors with Chronic Glomerulonephritis. In the examination of the kidney transplant recipients subgroup the results differed slightly, as only four of the aforementioned proteins showed a significant difference between progresors and non-progresors. In the subgroup of patients with albuminuria <150 mg / g only one biomarker levels differed significantly between 19 progresors and 105 non-progresors.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntrinias, Theodoros
- Ντρίνιας, Θεόδωρος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48690